Ligand binding induces Cbl-dependent EphB1 receptor degradation through the lysosomal pathway

Area of Science:

• Cellular signaling pathways
• Molecular mechanisms of receptor tyrosine kinase regulation

Background:

• Eph receptor tyrosine kinases (RTKs) are crucial for development and implicated in adult carcinogenesis and pathological neovascularization.
• The precise molecular mechanisms governing EphB1's role in tumor formation and metastasis are not fully understood.

Purpose of the Study:

• To elucidate the molecular mechanisms responsible for the downregulation of EphB1 protein.
• To investigate the role of Cbl ubiquitin ligase in EphB1 regulation.

Main Methods:

• Stimulation of EphB1 with ephrinB1/Fc and assessment of EphB1 protein levels.
• Use of lysosomal inhibitor bafilomycin and Src inhibitor PP2.
• Overexpression of wild-type and mutant Cbl.
• Kinase-dead EphB1 mutant experiments.
• Glutathione S-transferase (GST) binding assays.

Main Results:

• EphrinB1 stimulation induced EphB1 protein downregulation, which was blocked by bafilomycin.
• Cbl was recruited to EphB1, phosphorylated, and mediated EphB1 ubiquitination, dependent on Src kinase activity.
• Wild-type Cbl enhanced EphB1 ubiquitination and degradation, requiring EphB1 kinase activity.
• Cbl bound to EphB1 via its tyrosine kinase-binding domain.

Conclusions:

• Cbl ubiquitin ligase mediates the ubiquitination and lysosomal degradation of activated EphB1.
• This process requires the kinase activity of both EphB1 and Src.
• This study provides the first detailed molecular mechanism for EphB1 downregulation, offering potential targets for modulating angiogenic and tumorigenic properties.